Clinical trials: Tularemia

Tularemia

Safety and Immunogenicity Study of a Live Francisella Tularensis Vaccine

• Completed
• Age: 17 to 65 years
• Phase 2
• Vaccines
• Results posted

This study is designed to determine the safety and immunogenicity of a Live Francisella tularensis Vaccine

Trial name

NCT00584844

Testing

Live F tularensis Vaccine

Where

United States

Volunteers

484 people, healthy volunteers welcome

Sponsor

U.S. Army Medical Research and Development Command